NCT01850615 Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01849289 A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01848002 Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01847989 Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01846312 An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes Status COMPLETED Phase N/A
NCT01836523 The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01835431 A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01831765 Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01830712 A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors Status COMPLETED Phase N/A
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Status COMPLETED Phase PHASE4
NCT01821846 Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01819129 Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01814137 A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily Status COMPLETED Phase PHASE3
NCT01809184 A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01796366 A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01795248 The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes Status COMPLETED Phase PHASE4
NCT01795235 Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones Status UNKNOWN Phase NA
NCT01789593 A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01789086 A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years Status COMPLETED Phase PHASE1